Abstract Body

Antiretroviral therapy (ART) has reduced incidence of Kaposi’s sarcoma and several types of lymphoma. However, the impact of ART on risk of developing other cancers is less certain, particularly in sub-Saharan Africa where the great majority of HIV-infected individuals live. Botswana has nearly achieved the UNAIDS 90-90-90 targets. We sought to estimate the excess risk for cancer among people living with HIV in Botswana in the setting of high ART coverage.

We prospectively enrolled consenting patients presenting for specialized oncology care at the four principal treatment centers in Botswana (October 2010 to September 2017). Patients with unknown HIV status were tested. Cancer diagnoses were abstracted from clinical and pathologic records. After finding similar time to diagnosis and similar cancer stage, we assumed non-differential case capture by HIV status. We utilized population-representative data from the Botswana AIDS Incidence Survey (2013) to estimate age- and sex-standardized incidence ratios (SIR).

A total of 2700 patients with cancer were enrolled, including 1477 (54.7%) with HIV and 1140 (42.2%) without HIV. Eighty-three patients (3.1%) with unknown HIV status were excluded from further analyses. The majority (68.2%) of cancer patients were women. For HIV-infected patients, median current CD4 cell count was 355 cells/μL (IQR 213 to 543) and 1189 (82.5%) were on ART at the time of their cancer diagnosis (median ART duration 4.8 years [IQR 1.2 to 8.8 years]). Of the 1075 with an available measurement (90.4%), 1028 (95.6%) had HIV viral load < 1000 copies/mL. Patients living with HIV were 3.3-fold more likely to develop cancer (95%CI 3.1 to 3.5) and excess risk was similar for men (SIR 3.5, 95%CI 3.2 to 3.9) and women (SIR 3.2 95%CI 3.0 to 3.4). With exception of breast and head and neck cancer, HIV was significantly associated with increased risk for all cancer types; estimated SIRs for individual cancers are shown in the Table. HIV infection accounted for an estimated 39.3% of cancer cases (population attributable fraction).

With ART coverage exceeding 80%, more than a third of cancer cases are attributable to HIV infection in Botswana. Cancers in HIV-infected populations remain a large public health challenge and strategies to mitigate this burden are urgently needed.